搜索临床试验以:PD-1配体抑制剂
总计4668个结果
-
3D Medicines (Sichuan) Co., Ltd.招聘中
-
Fujian Cancer HospitalSuzhou Suncadia Biopharmaceuticals Co., Ltd.招聘中
-
Liang PengGuangzhou Virotech Pharmaceutical Co., Ltd.未知晚期/转移性肝细胞癌
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central Hospital撤销
-
Shanghai Junshi Bioscience Co., Ltd.未知
-
Jason J. Luke, MDBristol-Myers Squibb招聘中
-
Peking University招聘中
-
The Fourth Affiliated Hospital of Zhejiang University...招聘中
-
Shanghai Junshi Bioscience Co., Ltd.Iqvia Pty Ltd; TopAlliance Biosciences, Inc.主动,不招人
-
City of Hope Medical CenterNational Cancer Institute (NCI)招聘中
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Merck Sharp & Dohme LLC招聘中
-
Providence Health & ServicesMerck Sharp & Dohme LLC; Providence Cancer Center, Earle A. Chiles Research Institute主动,不招人
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University招聘中
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)完全的解剖学 IV 期乳腺癌 AJCC v8 | 预后 IV 期乳腺癌 AJCC v8 | 转移性乳腺癌美国
-
Sun Yat-sen UniversityJiangsu HengRui Medicine Co., Ltd.; Shanghai Junshi Bioscience Co., Ltd.招聘中
-
RenJi HospitalShanghai Zhongshan Hospital; Ruijin Hospital招聘中
-
Sun Yat-sen UniversityGuangzhou No.12 People's Hospital; Kaiping Central Hospital撤销
-
LiuYing尚未招聘大肠癌 | 新辅助治疗 | 错配修复缺陷 (dMMR) | 微卫星高不稳定性 (MSI-H)中国
-
H. Lee Moffitt Cancer Center and Research Institute撤销
-
University of Wisconsin, MadisonBristol-Myers Squibb; National Cancer Institute (NCI); AnYxis Immuno-Oncology GmbH; Provenance Biopharmaceuticals暂停
-
Fifth Affiliated Hospital, Sun Yat-Sen University招聘中
-
Sun Yat-sen UniversityChipscreen Biosciences, Ltd.尚未招聘复发或难治性 DLBCL
-
Sun Yat-sen UniversityChongqing University Cancer Hospital; Xiangya Hospital of Central South University; Tongji Hospital 和其他合作者招聘中
-
Peking University Cancer Hospital & Institute招聘中
-
Hoffmann-La Roche完全的鳞状非小细胞肺癌美国, 西班牙, 法国, 澳大利亚, 德国, 台湾, 加拿大, 阿根廷, 比利时, 新加坡, 巴西, 荷兰, 以色列, 葡萄牙, 俄罗斯联邦, 日本, 意大利, 智利, 拉脱维亚, 秘鲁, 乌克兰, 立陶宛, 斯洛伐克, 保加利亚, 墨西哥, 奥地利
-
Sunshine Guojian Pharmaceutical (Shanghai) Co.,...尚未招聘
-
Anwaar SaeedAstraZeneca; Exelixis主动,不招人
-
University of PennsylvaniaParker Institute for Cancer Immunotherapy; Tmunity Therapeutics终止